News
Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...
Headache trajectories vary for postmenopausal women who use menopausal hormone therapy, according to a poster presented at ...
Adults taking a high antihistamine dose vs. placebo before endurance exercise training sessions had less improvement in peak ...
No significant difference in mortality was observed at 96 hours among children with severe acute malnutrition and ...
A pharmacogenetics score may help physicians predict which patients with acute myeloid leukemia are more likely to respond to ...
The American College of Rheumatology is “disappointed” in the reductions to Medicaid funding included in the newly signed One ...
Male adolescents who underwent bariatric surgery had an increase in free testosterone after surgery that was not tied to a ...
Concurrent use of menopausal hormone therapy may augment the weight loss benefits of tirzepatide for postmenopausal women ...
Obesity-related cancer deaths increased more than threefold between 1999 and 2020, according to an analysis of the CDC WONDER ...
In this video from Clinical Trials at the Summit, Lejla Vajzovic, MD, FASRS, of Duke Eye Center, discusses tyrosine kinase inhibitors and gene therapy as different approaches for wet age-related ...
Initiating pharmacological treatment in patients aged at least 80 years who have had a fracture appears to be beneficial, researchers reported at ENDO 2025. Gianina Flocco, MD, a resident at Cleveland ...
In patients with acquired hypothalamic obesity, setmelanotide reduced BMI at 52 weeks compared with placebo, according to results of the TRANSCEND trial presented at ENDO 2025. For the phase 3 trial, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results